Comparative review evaluates canine leptospirosis vaccine formulations and safety profiles, highlighting the need to match local serovars and optimize schedules.
This article examines issues related to vaccinating dogs against leptospirosis, which receives particular attention as a zoonotic disease. Despite the extensive arsenal of leptospirosis vaccines, questions remain about their compliance with important criteria: the etiologic structure of the vaccine in the country, the presence of an adjuvant, as well the administration schedule and duration of the immune response. The issue of adverse reactions after vaccination is raised.
No takes yet. Share an insight, caveat, or question.
Soboleva et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: